Suzanne L. Hansen

611 total citations
16 papers, 495 citations indexed

About

Suzanne L. Hansen is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Suzanne L. Hansen has authored 16 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in Suzanne L. Hansen's work include Neuroscience and Neuropharmacology Research (14 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Ion channel regulation and function (3 papers). Suzanne L. Hansen is often cited by papers focused on Neuroscience and Neuropharmacology Research (14 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Ion channel regulation and function (3 papers). Suzanne L. Hansen collaborates with scholars based in Denmark, United Kingdom and Mali. Suzanne L. Hansen's co-authors include Connie Sánchez, Joanna C. Neill, Niels Plath, Bjarne Fjalland, Uffe Kristiansen, Henrik Tang Vestergaard, Meyer B. Jackson, Arne Schousboe, Sékou Bah and Mikael E. Pedersen and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Suzanne L. Hansen

16 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne L. Hansen Denmark 12 307 206 65 61 57 16 495
Cathy L. Bell-Horner United States 10 401 1.3× 284 1.4× 50 0.8× 40 0.7× 85 1.5× 11 668
Kulkarni Sk India 15 237 0.8× 160 0.8× 73 1.1× 80 1.3× 82 1.4× 68 566
Fathi M. Sherif Libya 14 253 0.8× 92 0.4× 70 1.1× 68 1.1× 54 0.9× 45 489
Marcelo Duzzioni Brazil 14 247 0.8× 172 0.8× 102 1.6× 40 0.7× 78 1.4× 32 566
Rosario Marra Italy 12 248 0.8× 173 0.8× 64 1.0× 22 0.4× 132 2.3× 18 472
Junli Zhen China 15 196 0.6× 216 1.0× 156 2.4× 24 0.4× 46 0.8× 21 669
Vincenzo Di Matteo Italy 13 563 1.8× 303 1.5× 75 1.2× 35 0.6× 86 1.5× 19 901
Turgay Çelik Türkiye 14 254 0.8× 154 0.7× 108 1.7× 19 0.3× 20 0.4× 25 482
Linda D. Mercer Australia 17 488 1.6× 337 1.6× 128 2.0× 24 0.4× 25 0.4× 29 858

Countries citing papers authored by Suzanne L. Hansen

Since Specialization
Citations

This map shows the geographic impact of Suzanne L. Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne L. Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne L. Hansen more than expected).

Fields of papers citing papers by Suzanne L. Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne L. Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne L. Hansen. The network helps show where Suzanne L. Hansen may publish in the future.

Co-authorship network of co-authors of Suzanne L. Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne L. Hansen. A scholar is included among the top collaborators of Suzanne L. Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne L. Hansen. Suzanne L. Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Hansen, Suzanne L., et al.. (2012). Does brain slices from pentylenetetrazole-kindled mice provide a more predictive screening model for antiepileptic drugs?. European Journal of Pharmacology. 682(1-3). 43–49. 4 indexed citations
3.
Walls, Anne B., Elvar M. Eyjolfsson, Henrik Tang Vestergaard, et al.. (2010). GAD65 is essential for synthesis of GABA destined for tonic inhibition regulating epileptiform activity. Journal of Neurochemistry. 115(6). 1398–1408. 46 indexed citations
4.
Plath, Niels, et al.. (2010). Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia. Psychopharmacology. 214(2). 403–413. 39 indexed citations
6.
Hansen, Suzanne L., Andreas Artmann, Gitte Petersen, et al.. (2008). Ketogenic diet is antiepileptogenic in pentylenetetrazole kindled mice and decrease levels of N-acylethanolamines in hippocampus. Neurochemistry International. 54(3-4). 199–204. 34 indexed citations
7.
Pedersen, Mikael E., Henrik Tang Vestergaard, Suzanne L. Hansen, et al.. (2008). Pharmacological screening of Malian medicinal plants used against epilepsy and convulsions. Journal of Ethnopharmacology. 121(3). 472–475. 42 indexed citations
8.
Lolli, Marco L., Suzanne L. Hansen, Barbara Rolando, et al.. (2006). Hydroxy-1,2,5-oxadiazolyl Moiety as Bioisoster of the Carboxy Function. Synthesis, Ionization Constants, and Pharmacological Characterization of γ-Aminobutyric Acid (GABA) Related Compounds. Journal of Medicinal Chemistry. 49(14). 4442–4446. 23 indexed citations
9.
White, H. Steve, William P. Watson, Suzanne L. Hansen, et al.. (2005). First Demonstration of a Functional Role for Central Nervous System Betaine/γ-Aminobutyric Acid Transporter (mGAT2) Based on Synergistic Anticonvulsant Action among Inhibitors of mGAT1 and mGAT2. Journal of Pharmacology and Experimental Therapeutics. 312(2). 866–874. 61 indexed citations
10.
Moesgaard, Birthe, Henrik H. Hansen, Suzanne L. Hansen, et al.. (2003). Brain levels of N‐acylethanolamine phospholipids in mice during pentylenetetrazol‐induced seizure. Lipids. 38(4). 387–390. 18 indexed citations
11.
Hansen, Suzanne L., et al.. (2003). Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(1). 105–113. 119 indexed citations
12.
Hansen, Suzanne L., Bjarne Fjalland, & Meyer B. Jackson. (2003). Modulation of GABAA Receptors and Neuropeptide Secretion by the Neurosteroid Allopregnanolone in Posterior and Intermediate Pituitary. Pharmacology & Toxicology. 93(2). 91–97. 9 indexed citations
13.
Hansen, Suzanne L., Bjarke Ebert, Bjarne Fjalland, & Uffe Kristiansen. (2001). Effects of GABAA receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions. British Journal of Pharmacology. 133(4). 539–549. 16 indexed citations
14.
Kristiansen, Uffe, et al.. (2001). GABAA receptor subunit interactions important for benzodiazepine and zinc modulation: a patch‐clamp and single cell RT‐PCR study. European Journal of Neuroscience. 13(9). 1673–1682. 17 indexed citations
15.
Hansen, Suzanne L., Bjarne Fjalland, & Meyer B. Jackson. (1999). Differential Blockade of γ-Aminobutyric Acid Type A Receptors by the Neuroactive Steroid Dehydroepiandrosterone Sulfate in Posterior and Intermediate Pituitary. Molecular Pharmacology. 55(3). 489–496. 9 indexed citations
16.
Hansen, Suzanne L., Bjarne Fjalland, & Meyer B. Jackson. (1999). Differential blockade of gamma-aminobutyric acid type A receptors by the neuroactive steroid dehydroepiandrosterone sulfate in posterior and intermediate pituitary.. PubMed. 55(3). 489–96. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026